These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 21365257)
21. The use of pluripotent stem cell for personalized cell therapies against neurological disorders. Ha HY; Jang SH; Jung JW J Biomed Biotechnol; 2011; 2011():520816. PubMed ID: 22203784 [TBL] [Abstract][Full Text] [Related]
22. Generation of skeletal muscle cells from embryonic and induced pluripotent stem cells as an in vitro model and for therapy of muscular dystrophies. Salani S; Donadoni C; Rizzo F; Bresolin N; Comi GP; Corti S J Cell Mol Med; 2012 Jul; 16(7):1353-64. PubMed ID: 22129481 [TBL] [Abstract][Full Text] [Related]
23. Very small embryonic-like stem cells are involved in regeneration of mouse pancreas post-pancreatectomy. Bhartiya D; Mundekar A; Mahale V; Patel H Stem Cell Res Ther; 2014 Sep; 5(5):106. PubMed ID: 25182166 [TBL] [Abstract][Full Text] [Related]
24. Homologous recombination in human iPS and ES cells for use in gene correction therapy. Nakayama M Drug Discov Today; 2010 Mar; 15(5-6):198-202. PubMed ID: 20116450 [TBL] [Abstract][Full Text] [Related]
26. Therapeutic potential of lung epithelial progenitor cells derived from embryonic and induced pluripotent stem cells. Wetsel RA; Wang D; Calame DG Annu Rev Med; 2011; 62():95-105. PubMed ID: 21226612 [TBL] [Abstract][Full Text] [Related]
27. Direct reprogramming of rat neural precursor cells and fibroblasts into pluripotent stem cells. Chang MY; Kim D; Kim CH; Kang HC; Yang E; Moon JI; Ko S; Park J; Park KS; Lee KA; Hwang DY; Chung Y; Lanza R; Kim KS PLoS One; 2010 Mar; 5(3):e9838. PubMed ID: 20352099 [TBL] [Abstract][Full Text] [Related]
28. Hematopoietic cells from primate embryonic stem cells. Li F; Lu SJ; Honig GR Methods Enzymol; 2006; 418():243-51. PubMed ID: 17141039 [TBL] [Abstract][Full Text] [Related]
29. iPS cells: a source of cardiac regeneration. Yoshida Y; Yamanaka S J Mol Cell Cardiol; 2011 Feb; 50(2):327-32. PubMed ID: 21040726 [TBL] [Abstract][Full Text] [Related]
30. Neuronal differentiation potential of mouse induced pluripotent stem cells. Yao XL; Liu Q; Ye CH; Li ZP; Lu XL; Li PL; Li XB; Li WQ Neuroreport; 2011 Oct; 22(14):689-95. PubMed ID: 21849916 [TBL] [Abstract][Full Text] [Related]
31. Induced pluripotent stem cells (iPSCs) derived from different cell sources and their potential for regenerative and personalized medicine. Shtrichman R; Germanguz I; Itskovitz-Eldor J Curr Mol Med; 2013 Jun; 13(5):792-805. PubMed ID: 23642060 [TBL] [Abstract][Full Text] [Related]
32. Differentiation of induced pluripotent stem cells into functional oligodendrocytes. Czepiel M; Balasubramaniyan V; Schaafsma W; Stancic M; Mikkers H; Huisman C; Boddeke E; Copray S Glia; 2011 Jun; 59(6):882-92. PubMed ID: 21438010 [TBL] [Abstract][Full Text] [Related]
33. New approaches in the differentiation of human embryonic stem cells and induced pluripotent stem cells toward hepatocytes. Behbahan IS; Duan Y; Lam A; Khoobyari S; Ma X; Ahuja TP; Zern MA Stem Cell Rev Rep; 2011 Sep; 7(3):748-59. PubMed ID: 21336836 [TBL] [Abstract][Full Text] [Related]
34. Making gametes from alternate sources of stem cells: past, present and future. Bhartiya D; Anand S; Patel H; Parte S Reprod Biol Endocrinol; 2017 Nov; 15(1):89. PubMed ID: 29145898 [TBL] [Abstract][Full Text] [Related]
35. A plethora of human pluripotent stem cells. Gao L; Thilakavathy K; Nordin N Cell Biol Int; 2013 Sep; 37(9):875-87. PubMed ID: 23619972 [TBL] [Abstract][Full Text] [Related]